GSK2636771 CAS#: 1372540-25-4

ChemicalBook > Product Catalog > Biochemical Engineering > Inhibitors > PI3K / Akt / mTOR > PI3K inhibitor > GSK2636771

GSK2636771

Basic information Safety Supplier Related

Product Name:

GSK2636771

Synonyms:

GSK2636771
2-Methyl-1-[[2-Methyl-3-(trifluoroMethyl)phenyl]Methyl]-6-(4-Morpholinyl)-1H-benziMidazole-4-carboxylic acid
GSK2636771/GSK-2636771
GSK 2636771 dihydrochloride
2-Methyl-1-(2-methyl-3-(trifluoromethyl)benzyl)-6-morpholino-1H-benzo[d]imidazole-4-carboxylic
1H-Benzimidazole-4-carboxylic acid, 2-methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)-
2-Methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acid GSK2636771
2-METHYL-1-[[2-METHYL-3-(TRIFLUOROMETHYL)PHENYL]METHYL]-6-MORPHOLIN-4-YLBENZIMIDAZOLE-4-CARBOXYLIC ACID

CAS:

1372540-25-4

MF:

C22H22F3N3O3

MW:

433.42

Product Categories:

Mol File:

1372540-25-4.mol

Less

Melting point:: >225°C (dec.)
Boiling point:: 641.3±55.0 °C(Predicted)
Density: 1.38
storage temp.: -20°C Freezer
solubility: DMSO (Slightly), Methanol (Slightly)
pka: -2.70±0.30(Predicted)
form: Solid
color: Pale Yellow
InChI: InChI=1S/C22H22F3N3O3/c1-13-15(4-3-5-18(13)22(23,24)25)12-28-14(2)26-20-17(21(29)30)10-16(11-19(20)28)27-6-8-31-9-7-27/h3-5,10-11H,6-9,12H2,1-2H3,(H,29,30)
InChIKey: XTKLTGBKIDQGQL-UHFFFAOYSA-N
SMILES: C1(C)N(CC2=CC=CC(C(F)(F)F)=C2C)C2=CC(N3CCOCC3)=CC(C(O)=O)=C2N=1

Less

GSK2636771 is a potent, orally bioavailable, PI3Kβ-selective inhibitor, sensitive to PTEN null cell lines.

Shanghai Lollane Biological Technology Co.,Ltd. Gold

Hubei Chuchang Chemical Co., Ltd Gold

Shanghai Boyle Chemical Co., Ltd.

Chembest Research Laboratories Limited

Jinan Trio PharmaTech Co., Ltd.

Less